Wegovy for Women: How It Works, Who It Suits, and What to Expect

Does Wegovy work differently in women than in men?

The short answer is: not in its mechanism, but the context of treatment often differs. Semaglutide acts on GLP-1 receptors in the brain and gut regardless of sex, it reduces appetite signals and slows the rate at which the stomach empties. What does vary is the weight-related picture that many women bring to treatment. Hormonal shifts across the menstrual cycle, perimenopause, PCOS, and conditions like hypothyroidism all interact with body weight in ways that a prescriber takes into account during assessment.

The STEP 1 clinical trial, published in the New England Journal of Medicine, enrolled women and men; the headline average weight loss of around 15% over 68 weeks reflects the full participant group. Individual results varied, some participants lost considerably more, others less. Framing this as a predictable figure for any one person would be misleading, which is why a thorough clinical assessment matters before treatment begins.

For a broader look at how semaglutide interacts with women's health specifically, the benefits of semaglutide for women page covers PCOS, metabolic health and hormonal context in more depth. There is also a growing body of interest in how appetite changes on treatment affect energy and mood, something our prescribers hear about regularly. Men considering the same treatment can find out more on the Wegovy weight loss for men page, which looks at how the treatment fits the specific health context men typically bring to it.

What should women know about contraception and Wegovy?

This is one of the most practically important questions, and it does not get enough attention. Because Wegovy slows gastric emptying, there is a theoretical risk that oral medicines (including the combined pill) may be absorbed less reliably, particularly early in treatment when GI effects tend to be strongest.

NHS guidance notes that, for semaglutide specifically, there is not currently the same evidence of reduced pill effectiveness seen with tirzepatide. That said, NHS England's guidance on weight-management injections advises discussing contraception with your prescriber before starting, particularly if you use oral hormonal contraception. Adding a barrier method during dose escalation is a sensible precaution many clinicians recommend.

Wegovy is not licensed for use during pregnancy or breastfeeding. It is also not recommended for women who are trying to conceive. If your circumstances change after you start treatment, contact your prescriber promptly rather than waiting for a scheduled review. Women using HRT alongside semaglutide should also flag this at consultation, transdermal options such as patches or gels avoid the absorption question entirely.

Questions about how Wegovy may interact with libido or sexual wellbeing are covered separately on the Wegovy and libido page, which draws on what the evidence currently does and does not show.

What side effects do women on Wegovy most often report?

The most common side effects are gastrointestinal: nausea, loose stools, constipation, reflux and burping. These tend to be most noticeable in the first weeks after starting or after a dose increase, and most people find they settle considerably as the body adjusts. Fatigue and headache are also reported, particularly in the early weeks.

Nausea is the one women ask about most. Eating slowly, keeping portions modest and avoiding very fatty or spicy meals helps a lot, as does not lying down straight after eating. These are not tips that require a prescription, they are practical habits that make the adjustment period more manageable.

One nutritional consideration specific to women on Wegovy: because appetite falls significantly, it becomes easier to under-eat protein and micronutrients even without intending to. Bone health, iron status and adequate folate matter particularly for women of reproductive age. The best multivitamin choices for women on Wegovy page summarises what to look for. The NHS semaglutide medicines page also lists the full side-effect profile and advises when to seek urgent medical advice.

Seek urgent medical help if you develop severe, persistent stomach pain that radiates to your back, this can be a sign of pancreatitis, a known but uncommon side effect of GLP-1 medicines. Any suspected side effects can be reported directly to the MHRA via the Yellow Card scheme.

Is Wegovy available on the NHS for women, and how does private treatment compare?

NHS access to Wegovy is through specialist weight management services under NICE's guidance (TA875), and waiting lists can be long. Private treatment through a regulated pharmacy removes the wait and the referral requirement, though it costs more. Understanding that context is worth your time before deciding which route suits you.

If you are weighing up costs, the Wegovy price comparison page sets out what private treatment typically costs across the market and what legitimate pricing includes, prescription, clinical review and delivery, not just the pen itself. For the question of whether Wegovy is likely to be appropriate for your situation, the is Wegovy for me page walks through the eligibility criteria in plain language.

One thing that catches people out: orders placed before noon on a weekday are dispatched the same day once clinically approved, handy to know if you are timing a first order around a holiday or a busy week ahead. For women who have already explored the broader treatment landscape, a comparison with the tirzepatide-based alternative is available on the weight-loss treatments overview.

Wegovy is not the right choice for everyone, and a prescriber's job is to tell you that honestly if it is not. Speak to our prescribers through a free consultation to get a straightforward assessment of whether this treatment suits your specific circumstances.